Navigation Links
Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
Date:10/25/2010

FORT LEE, N.J., Oct. 25 /PRNewswire-FirstCall/ -- Neurologix, Inc. (OTC Bulletin Board: NRGX) today announced that a landmark paper, published on October 20th in Science Translational Medicine demonstrating the importance of the p11 gene in modulating depression in mice, utilized a gene therapy approach to reverse depression in mice for which the Company holds exclusive development rights.  Based on the findings reported in the paper, gene therapy may have potential as a new treatment option for people who suffer from severe depression.In the study, reduced levels of the p11 protein in the nucleus accumbens (NAcc) of the brain were associated with depressive behaviors in mice.  An AAV vector (adeno-associated virus, a disabled, non-pathogenic virus) was used to deliver the p11 gene back into the NAcc of mice who were lacking the p11 protein, reversing the depressive behavior and returning the animals to normal function.  

The study also examined samples of brain tissue from a group of deceased human patients, half of whom had severe depression.  It was found that there were significantly reduced levels of p11 in the NAcc of depressed patients compared to those without depression.  This further highlights the importance of this research in providing a new avenue for future treatment of this widespread disorder.

Neurologix holds the exclusive license to a patent for p11 gene therapy in the treatment of psychiatric conditions, including depression, from Cornell University for and on behalf of the Joan & Sanford I. Weill Medical College.  Neurologix scientific co-founder Michael G. Kaplitt, MD, PhD, is co-inventor on the patent, and is the senior author of the research paper.

"The publication of this important research validates our decision to secure the license for developing p11 gene therapy for eventual use in people with
'/>"/>

SOURCE Neurologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , Sept. 1, 2015   Millstone Medical ... 120,000 square feet in Olive Branch, MS. ... Olive Branch facility has added the capacity required ... "This expansion gives us the opportunity to ... , President of Millstone MS. "Two and a half years ...
(Date:9/1/2015)... Sargas Pharmaceutical Adherence and Compliance (SPAC) ... m Health applications along with 24 hour medication ... face-to-face monitoring of twenty minutes per month. ... apps, doctors are now well prepared to deliver ... certified Physician, Pharmacy and Patient portals that help ...
(Date:9/1/2015)... ANGELES , Sept. 1, 2015 ... research and development company specializing in oncology, today ... and Chief Executive Officer, and David Haen ... Relations, will present a corporate overview at two ... the biotechnology and healthcare industries: the FBR & ...
Breaking Medicine Technology:Millstone Medical Outsourcing Announces Olive Branch Expansion 2SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 4
(Date:9/2/2015)... ... September 02, 2015 , ... Pentec Health, Inc., a national ... List for an impressive sixth consecutive year. Less than 5 % of this year’s ... in the “health” sector. Pentec’s 3-year revenue growth rate of 65% sustained its ...
(Date:9/2/2015)... ... September 02, 2015 , ... This Fall, ... Month (BCAM), Bright Pink, a national non-profit focused on the prevention and early ... Facts, a campaign to educate women to be breast and ovarian self-aware and ...
(Date:9/1/2015)... ... September 01, 2015 , ... Dr. Michael Rothman, ... about medicine and health, truths that other doctors and professionals may be reluctant ... regularly debunk certain misconceptions surrounding cholesterol, metabolically directed wellness, anti-aging, and more. Access ...
(Date:9/1/2015)... ... ... September is National Prostate Cancer Awareness Month and Florida Hospital Zephyrhills wants to ... the United States. , Prostate cancer is to men what breast cancer is to ... men. One new case occurs every 2.3 minutes and a man dies from prostate ...
(Date:9/1/2015)... ... ... The Journal of Pain Research has published the original research “ Migraine: ... Mr Christopher Malone says “Migraine headache is a painful chronic condition affecting millions of ... migraine headaches impact the lives of migraineurs. We asked migraineurs about a variety of ...
Breaking Medicine News(10 mins):Health News:Pentec Health Once Again Named One of the Fastest-Growing Private Companies in America 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 3Health News:Dr. Michael Rothman, NJ’s Leading Holistic Doctor, Presents a Video Blog that Discusses the Most Confusing and Interesting Current Medical Topics 2Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2
... Averting second, possibly deadly, attack is long-term goal, researchers say ... developed a tool to predict whether a patient will suffer ... , "This is an important new tool because studies have ... a first stroke are more likely to die or have ...
... University of Florida researchers at work on a malaria elimination ... spread of the disease using cell phone records. The ... often residents of Zanzibar travel and where they go. A ... Tanzania in East Africa, Zanzibar has drastically reduced malaria in ...
... found, , WEDNESDAY, Dec. 16 (HealthDay News) -- E. coli ... the stomach pain and diarrhea that result -- might also ... have found the same strains of the bacteria in chicken ... , There,s no evidence that the germs were transmitted ...
... 8 percent of children are uninsured, government report finds , ... months of this year, 45.4 million Americans of all ages ... health insurance, according to new National Health Interview Survey statistics ... of all ages had been uninsured for at least part ...
... , NEW ORLEANS, Dec. 16 A new ... takes for inpatient healthcare facilities to calculate their staffing needs ... Census allows inpatient healthcare facilities to calculate their mandatory ... and receive a daily report as to how it affects ...
... DNA of a 1st century shrouded man found in a tomb ... the earliest proven case of leprosy. Details of the research will ... The molecular investigation was undertaken by Prof. Mark Spigelman and ... the Study of Infectious and Tropical Diseases at the Hebrew University ...
Cached Medicine News:Health News:New Stroke Tool May Predict Early Recurrence 2Health News:Scientists use cell phone records to predict spread of malaria 2Health News:Scientists use cell phone records to predict spread of malaria 3Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 2Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 3Health News:Over 45 Million Americans Now Lack Health Insurance 2Health News:United States Patent Office Allows CareRise Patent on 24/7 Staff-Census Software 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: